Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to $318.6 million.

  • Core Scientific's Shares Outstanding (Weighted Average) rose 891.53% to $318.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $318.6 million, marking a year-over-year increase of 891.53%. This contributed to the annual value of $255.8 million for FY2024, which is 3265.15% down from last year.
  • As of Q3 2025, Core Scientific's Shares Outstanding (Weighted Average) stood at $318.6 million, which was up 891.53% from $318.0 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Shares Outstanding (Weighted Average) peaked at $382.5 million during Q3 2023, and registered a low of $157.8 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $291.6 million, with a median of $315.2 million in 2025.
  • In the last 5 years, Core Scientific's Shares Outstanding (Weighted Average) skyrocketed by 10452.33% in 2022 and then tumbled by 4490.4% in 2024.
  • Core Scientific's Shares Outstanding (Weighted Average) (Quarter) stood at $207.3 million in 2021, then surged by 64.35% to $340.6 million in 2022, then grew by 11.51% to $379.9 million in 2023, then plummeted by 32.65% to $255.8 million in 2024, then grew by 24.52% to $318.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $318.6 million for Q3 2025, versus $318.0 million for Q2 2025 and $315.2 million for Q1 2025.